title: Drug-protein-binding determination of stilbene glucoside using cloud-point extraction and comparison with ultrafiltration and equilibrium dialysis.
abstract: OBJECTIVE
  We did a prospective study to investigate the binding of stilbene glucoside (2,3,5,4'-tetrahydroxystilbene-2-O-beta-D-glucoside, TSG) to plasma, albumin, and alpha1-AGP (2.0, 10.0, or 50 microg/mL) by three different methods: ultrafiltration, equilibrium dialysis and cloud-point extraction (CPE).
  
  
  METHODS
  Drug stability in plasma was assessed at different temperatures (4, 25, and 37 degrees C) and on the condition of thawing and freezing. A previously validated high-performance liquid chromatography (HPLC) method was used to analyze the total concentration of drug and free fraction in the samples.
  
  
  RESULTS
  The binding of TSG to plasma increased with adding drug concentration. The binding to albumin was constant (about 60%) within concentration range studied while the binding to alpha1-AGP decreased with increasing drug concentration indicating that albumin is more important in clinical settings.
  
  
  CONCLUSIONS
  alpha1-AGP might be important when plasma proteins change with disease. The results to plasma obtained by CPE were in good agreement to those observed by ultrafiltration and equilibrium dialysis, indicating that CPE was a highly sensitive and selective method for the measurement to plasma protein binding of TSG. The results obtained in our studies are important before clinical trials and to perform pharmacokinetic studies.
authors: Department of Pharmaceutical Analysis, School of Pharmacy, Hebei Medical University, Shijiazhuang, PR China.
authors: Chunying
authors: C
authors: Wang
authors: Qiao
authors: Q
authors: Wang
authors: Zhifang
authors: Z
authors: Yuan
authors: Weina
authors: W
authors: Liu
authors: Jianmin
authors: J
authors: Gu
authors: Lantong
authors: L
authors: Zhang
mesh_terms: D000465:Algorithms; D053000:Analytic Sample Preparation Methods; D000975:Antioxidants / Q000378:metabolism*; D001798:Blood Proteins / Q000378:metabolism*; D002851:Chromatography, High Pressure Liquid; D003956:Dialysis; D004355:Drug Stability; D005615:Freezing; D005960:Glucosides / Q000097:blood* / Q000378:metabolism*; D006801:Humans; D009961:Orosomucoid / Q000378:metabolism; D009994:Osmolar Concentration; D011485:Protein Binding; D012710:Serum Albumin, Bovine / Q000378:metabolism; D013267:Stilbenes / Q000097:blood* / Q000378:metabolism*; D013501:Surface-Active Agents; D013696:Temperature; D014462:Ultrafiltration
chemical_list: C489707:2',3',4',5'-tetrahydroxystilbene-2-O-beta-D-glucoside; D000975:Antioxidants; D001798:Blood Proteins; D005960:Glucosides; D009961:Orosomucoid; D013267:Stilbenes; D013501:Surface-Active Agents; D012710:Serum Albumin, Bovine